Related Experiment Video
Updated: May 9, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection
1Department of Biopharmaceutics, School of Pharmacy, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan. hnabe@kumamoto-u.ac.jp
Insights
Protein-bound uremic toxins like indoxyl sulfate (IS) and p-cresyl sulfate (PCS) contribute to chronic kidney disease (CKD) and cardiovascular disease (CVD) progression. Understanding their role in oxidative damage is key to developing new treatments.
Area of Science:
- Nephrology
- Cardiology
- Toxicology
Background:
- Chronic kidney disease (CKD) leads to dialysis and cardiovascular disease (CVD).
- CKD affects 13.3 million people in Japan, with 300,000 on hemodialysis.
- Preventing dialysis and CVD deaths is a public health priority, but CKD-CVD mechanisms are unclear.
Purpose of the Study:
- Investigate the role of protein-bound uremic toxins in CKD and CVD.
- Examine the relationship between the redox properties of these toxins and CKD-CVD pathogenesis.
- Focus on indoxyl sulfate (IS) and p-cresyl sulfate (PCS) to understand molecular mechanisms.
Main Methods:
- Review of recent studies on uremic toxins, oxidative stress, and cardiovascular-renal connections.
- Analysis of the impact of IS and PCS on CKD-CVD progression.
- Examination of redox properties of specific uremic toxins.
Main Results:
- Protein-bound uremic toxins, difficult to remove by hemodialysis, play a role in CKD and CVD.
- Indoxyl sulfate (IS) and p-cresyl sulfate (PCS) are implicated in CKD-CVD pathogenesis.
- These toxins induce oxidative tissue damage through a cardiovascular-renal connection.
Conclusions:
- Uremic toxins like IS and PCS contribute to CKD-CVD via oxidative stress.
- Understanding these molecular mechanisms is crucial for novel therapeutic strategies.
- Targeting uremic toxin-induced damage may prevent dialysis and reduce cardiovascular mortality.
Abstract:
Chronic kidney disease (CKD), marked by a progressive loss in renal function, is a leading cause of hemodialysis initiation and cardiovascular disease (CVD). There are currently 13.3 million patients with CKD and 300 thousand patients are currently undergoing hemodialysis in Japan. Therefore, preventing the initiation of dialysis and reducing the risk of cardiovascular death are high-priority issues from the viewpoint of public health and economic implications. Understanding the molecular mechanism responsible for the progression of CKD and cardiovascular damage regarding crosstalk between the kidney and cardiovascular system is an important issue in controlling the pathogenesis of CKD-CVD. However, the mechanisms involved in CKD-CVD are not well understood. This hinders the development of new treatment strategies. We have been investigating the role of protein bound uremic toxins, that are difficult to remove by hemodialysis, on the onset and progression of CKD and CVD. The relationship between their redox properties and the pathogenesis of CKD-CVD was examined. In this review, we focus on two sulfate conjugated uremic toxins, namely, indoxyl sulfate (IS) and p-cresyl sulfate (PCS), and summarize recent studies that provide new insights on the molecular mechanisms responsible for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Bioactivation and Tissue Toxicity
Acute Kidney Injury II: Pathophysiology
Cellular Injury I: Introduction
Drug Toxicity: Dose-Dependent Reactions
Cellular Injury IV: Necrosis
